Curcumin derivative C817 inhibits proliferation of imatinib …

Curcumin derivative C817 inhibits proliferation of imatinib …

AIM: To find new kinase inhibitors that overcome the imatinib resistance in treatment of chronic myeloid leukemia (CML), we synthesized C817, a novel derivative of curcumin, and tested its activities against wild-type (WT) and …

(Visited 1 times, 1 visits today)
8
Like
Save

Comments

Comments are disabled for this post.